Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor

Detalhes bibliográficos
Autor(a) principal: Oliveira, AM
Data de Publicação: 2016
Outros Autores: Santiago, I, Carvalho, R, Martins, A, Reis, J
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.10/1894
Resumo: Visceral angioedema is a rare complication of therapy with angiotensin-converting enzyme (ACE) inhibitors. Clinical presentation includes nausea, vomiting, abdominal pain and diarrhea. Early detection of this entity can prevent recurrent episodes and unnecessary invasive procedures, including surgery. This article describes a 46-year-old-woman who presented to the emergency department with abdominal pain, associated with nausea and vomiting. She had been taking ramipril for 15 days. A computed tomography was performed which revealed thickening of a jejunal segment, with submucosal edema. ACE inhibitor-associated angioedema was suspected and the medication was discontinued, with resolution of symptoms in 48 h. After 7 months of follow-up, the patient is asymptomatic. Despite of its rarity, ACE inhibitor-induced small-bowel angioedema should be included in the differential diagnosis when patients receiving ACE inhibitor therapy present with abdominal complaints.
id RCAP_9e2283816e1990e54bcf939f77f284a6
oai_identifier_str oai:repositorio.hff.min-saude.pt:10400.10/1894
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme InhibitorAngioedema Visceral Isolado Induzido por Inibidor da Enzima de Conversão da AngiotensinaAngioedemaAngiotensin-converting enzyme inhibitorsVisceral angioedema is a rare complication of therapy with angiotensin-converting enzyme (ACE) inhibitors. Clinical presentation includes nausea, vomiting, abdominal pain and diarrhea. Early detection of this entity can prevent recurrent episodes and unnecessary invasive procedures, including surgery. This article describes a 46-year-old-woman who presented to the emergency department with abdominal pain, associated with nausea and vomiting. She had been taking ramipril for 15 days. A computed tomography was performed which revealed thickening of a jejunal segment, with submucosal edema. ACE inhibitor-associated angioedema was suspected and the medication was discontinued, with resolution of symptoms in 48 h. After 7 months of follow-up, the patient is asymptomatic. Despite of its rarity, ACE inhibitor-induced small-bowel angioedema should be included in the differential diagnosis when patients receiving ACE inhibitor therapy present with abdominal complaints.Sociedade Portuguesa de GastrenterologiaRepositório do Hospital Prof. Doutor Fernando FonsecaOliveira, AMSantiago, ICarvalho, RMartins, AReis, J2017-07-04T13:25:04Z2016-01-01T00:00:00Z2016-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.10/1894engGE Port J Gastroenterol. 2016;23(3):162-1650872-8178info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-20T15:52:37Zoai:repositorio.hff.min-saude.pt:10400.10/1894Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:52:55.669459Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
Angioedema Visceral Isolado Induzido por Inibidor da Enzima de Conversão da Angiotensina
title Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
spellingShingle Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
Oliveira, AM
Angioedema
Angiotensin-converting enzyme inhibitors
title_short Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
title_full Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
title_fullStr Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
title_full_unstemmed Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
title_sort Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
author Oliveira, AM
author_facet Oliveira, AM
Santiago, I
Carvalho, R
Martins, A
Reis, J
author_role author
author2 Santiago, I
Carvalho, R
Martins, A
Reis, J
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Hospital Prof. Doutor Fernando Fonseca
dc.contributor.author.fl_str_mv Oliveira, AM
Santiago, I
Carvalho, R
Martins, A
Reis, J
dc.subject.por.fl_str_mv Angioedema
Angiotensin-converting enzyme inhibitors
topic Angioedema
Angiotensin-converting enzyme inhibitors
description Visceral angioedema is a rare complication of therapy with angiotensin-converting enzyme (ACE) inhibitors. Clinical presentation includes nausea, vomiting, abdominal pain and diarrhea. Early detection of this entity can prevent recurrent episodes and unnecessary invasive procedures, including surgery. This article describes a 46-year-old-woman who presented to the emergency department with abdominal pain, associated with nausea and vomiting. She had been taking ramipril for 15 days. A computed tomography was performed which revealed thickening of a jejunal segment, with submucosal edema. ACE inhibitor-associated angioedema was suspected and the medication was discontinued, with resolution of symptoms in 48 h. After 7 months of follow-up, the patient is asymptomatic. Despite of its rarity, ACE inhibitor-induced small-bowel angioedema should be included in the differential diagnosis when patients receiving ACE inhibitor therapy present with abdominal complaints.
publishDate 2016
dc.date.none.fl_str_mv 2016-01-01T00:00:00Z
2016-01-01T00:00:00Z
2017-07-04T13:25:04Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.10/1894
url http://hdl.handle.net/10400.10/1894
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv GE Port J Gastroenterol. 2016;23(3):162-165
0872-8178
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Gastrenterologia
publisher.none.fl_str_mv Sociedade Portuguesa de Gastrenterologia
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130395732606976